ABPI release statement on Ben Goldacre’s “Bad Pharma”
The Association of the British Pharmaceutical Industry (“ABPI”), the body that represents the big pharma suppliers, has released its reaction to the controversial new book, “Bad Pharma” by Ben...
View ArticleBen Goldacre challenges ABPI’s statement on his book, “Bad Pharma”
Ben Goldacre has stated in his “bad science” blog on 11 October 2012 that, “The ABPI claims that all the problems in my book are “historical”. This claim is simply untrue.” Ben Goldacre goes on to set...
View ArticleAlltrials campaign grows momentum for publishing all results of clinical trials
A campaign is gathering momentum to require all clinical trial data to be published. The petition at alltrials.net has thousands of signatures and comes in the wake of the popular book, Bad Pharma, by...
View ArticleHow bad and willing to change is pharma?
Yesterday, five of us from the Matthew Arnold & Baldwin LLP pharma and life sciences sector were privileged to attend what in our view was the pharma event of the year. If you were not there, you...
View Article
